PRESS RELEASE published on 10/06/2025 at 23:02, 8 months 15 days ago DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq DBV Technologies announces sale of $30 million of ADSs through its At-The-Market (ATM) program on Nasdaq. New ordinary shares will be issued to Invus. ADSs and Ordinary Shares represent 5 Ordinary Shares of the Company each Ordinary Shares Nasdaq Ads DBV Technologies At-the-market Program
PRESS RELEASE published on 10/06/2025 at 23:02, 8 months 15 days ago DBV Technologies annonce un placement d’ADS pour un montant d’environ 30 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq DBV Technologies annonce un placement d'ADS de 30 millions de dollars US dans le cadre de son programme ATM sur le Nasdaq. Les actions seront livrées le 8 octobre 2025 Financement Nasdaq Placement Ads DBV Technologies
BRIEF published on 09/18/2025 at 22:35, 9 months 3 days ago Board Member Resigns from DBV Technologies Resignation Biopharmaceutical Board Member DBV Technologies Viaskin Peanut
BRIEF published on 09/18/2025 at 22:35, 9 months 3 days ago Un membre du conseil d'administration démissionne de DBV Technologies Biopharmaceutique Démission DBV Technologies Membre Du Conseil D'administration VIASKIN Cacahuète
PRESS RELEASE published on 09/18/2025 at 22:30, 9 months 3 days ago DBV Technologies Announces Resignation of Board Member DBV Technologies announces the resignation of Board Member Daniel Soland. The company focuses on developing treatment options for food allergies with VIASKIN patch technology Resignation Board Member DBV Technologies Food Allergies VIASKIN Patch
PRESS RELEASE published on 09/18/2025 at 22:30, 9 months 3 days ago DBV Technologies annonce la démission d’un membre de son Conseil d’administration DBV Technologies annonce la démission de Daniel Soland de son Conseil d'administration Conseil D'administration Biopharmaceutique Démission DBV Technologies Daniel Soland
BRIEF published on 09/03/2025 at 22:35, 9 months 18 days ago DBV Technologies à la conférence H.C. Wainwright Global Investment DBV Technologies Allergies Alimentaires Conférence H.C. Wainwright Immunothérapie Épicutanée Patch VIASKIN®
BRIEF published on 09/03/2025 at 22:35, 9 months 18 days ago DBV Technologies at the HC Wainwright Global Investment Conference DBV Technologies Food Allergies HC Wainwright Lecture Epicutaneous Immunotherapy VIASKIN® Patch
PRESS RELEASE published on 09/03/2025 at 22:30, 9 months 18 days ago DBV Technologies participera à la 27e conférence annuelle H.C. Wainwright Global Investment DBV Technologies participera à la 27e conférence annuelle H.C. Wainwright Global Investment avec leur Directeur Général, Daniel Tassé, pour discuter de leur technologie exclusive VIASKIN® pour les allergies alimentaires DBV Technologies Allergies Alimentaires VIASKIN® 27e Conférence H.C. Wainwright Global Investment
BRIEF published on 08/01/2025 at 22:10, 10 months 20 days ago DBV Technologies : Bilan du Capital Social au 31 Juillet 2025 Droits De Vote Capital Social Actions DBV Technologies NYSE Euronext Paris
Published on 06/22/2026 at 15:58, 59 minutes ago Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement
Published on 06/22/2026 at 15:30, 1 hour 27 minutes ago NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
Published on 06/22/2026 at 15:00, 1 hour 57 minutes ago Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Published on 06/22/2026 at 14:01, 2 hours 56 minutes ago Worksport (NASDAQ:WKSP) Achieves 35% May Gross Margin, Lands Meyer Distribution, Targets $36M+ Revenue Run-Rate
Published on 06/22/2026 at 14:00, 2 hours 57 minutes ago Adcore Enters Strategic Partnership with TikTok as a Channel Sales Partner
Published on 06/22/2026 at 16:05, 52 minutes ago ACEMATE Tennis Robot S10 Gets $600 Prime Day Discount, with Bonus Gifts
Published on 06/22/2026 at 15:33, 1 hour 23 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/22/2026 at 15:32, 1 hour 24 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 06/22/2026 at 08:30, 8 hours 27 minutes ago Eiffage entre en négociation exclusive avec Atlas Arteria en vue d’acquérir la concession du tunnel de Warnow à Rostock, en Allemagne
Published on 06/22/2026 at 08:30, 8 hours 27 minutes ago Eiffage enters into exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
Published on 06/19/2026 at 19:33, 2 days 21 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 21 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026